FT3与老年缺血性心肌病伴心衰病人因心衰再入院的相关性研究

doi:10.3969/j.issn.1003-9198.2024.04.013

摘要/Abstract

摘要： 目的探讨老年缺血性心肌病伴心力衰竭(心衰)病人血清游离三碘甲状腺原氨酸(FT3)水平与病人因心衰再入院的相关性。方法选取2018年3月至2019年12月在南京大学医学院附属鼓楼医院心血管内科住院的89例老年缺血性心肌病伴心衰病人,根据此次入院是否为心衰再入院将病人分为心衰再入院组(24例)和非心衰再入院组(65例),比较2组病人住院期间的基线资料、血清学指标和超声心动图指标。采用多因素Logistic回归分析心衰再入院的相关因素。结果心衰再入院组男性比例低于非心衰再入院组,BNP、球蛋白水平高于非心衰再入院组,FT3水平低于非心衰再入院组(均P＜0.05);多因素Logistic回归分析显示,校正了射血分数(EF)、左室舒张末期内径(LVEDD)、BNP、球蛋白、性别、卒中等因素后,FT3水平下降是心力衰竭再入院的独立危险因素(OR=0.198, 95%CI:0.040~0.966)。结论 FT3水平下降是老年缺血性心肌病伴心衰病人因心衰再入院的独立危险因素。

关键词: FT3, 缺血性心肌病, 心力衰竭

Abstract: Objective To investigate the correlation between serum level of free triiodothyronine (FT3) and readmission due to heart failure in the elderly patients with ischemic cardiomyopathy and heart failure. Methods A total of 89 elderly patients with ischemic cardiomyopathy and heart failure admitted to Department of Vasculocardiology, Nanjing Drum Tower Hospital from March 2018 to December 2019 were enrolled. According to whether the readmission was due to heart failure, the patients were divided into heart failure readmission group (group A, n=24) and non-heart failure readmission group (group B, n=65). The baseline data, serological indexes and echocardiographic indexes of the two groups were compared during hospitalization. Multivariate Logistic regression was used to analyze the related factors of readmission due to heart failure. Results The proportion of male patients in group A was lower than that in group B, the levels of BNP and globulin were higher than those in group B, and the level of FT3 was lower than that in group B (all P<0.05). Multivariate Logistic regression analysis showed that after adjusting ejection fraction (EF), left ventricular end-diastolic diameter(LVEDD), BNP, globulin, gender, stroke and other factors, decreased FT3 was an independent risk factor for readmission due to heart failure (OR=0.198, 95%CI: 0.040-0.966). Conclusions Decreased FT3 is an independent risk factor for readmission due to heart failure in the elderly patients with ischemic cardiomyopathy and heart failure.

Key words: free triiodothyronine, ischemic heart disease, heart failure

中图分类号:

R 542.2

陈珊, 仲崇霞, 刘益海, 邹任方, 徐标, 倪杰, 沙杜鹃. FT3与老年缺血性心肌病伴心衰病人因心衰再入院的相关性研究[J]. 实用老年医学, 2024, 38(4): 382-385.

CHEN Shan, ZHONG Chongxia, LIU Yihai, ZOU Renfang, XU Biao, NI Jie, SHA Dujuan. Association of FT3 with readmissions due to heart failure in elderly patients with ischemic cardiomyopathy and heart failure[J]. Practical Geriatrics, 2024, 38(4): 382-385.

参考文献

[1] METRA M, TEERLINK J R. Heart failure [J]. Lancet, 2017, 390(10106): 1981-1995.
[2] KATZ D, GAVIN M C. Stable ischemic heart disease [J]. Ann Intern Med, 2019, 171(3): ITC17-ITC32.
[3] ELGENDY I Y, MAHTTA D, PEPINE C J. Medical therapy for heart failure caused by ischemic heart disease [J]. Circ Res, 2019, 124(11): 1520-1535.
[4] 李世军. 老年心力衰竭流行病学和病理生理学及预后的研究进展[J]. 中华老年心脑血管病杂志, 2021, 23(3): 318-320.
[5] 杨凯, 金明磊. 某三级医院住院老年心衰患者衰弱状况及影响因素分析[J]. 承德医学院学报, 2019, 36(1): 34-37.
[6] ZHANG K, WANG W, ZHAO S, et al. Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy [J]. Clin Cardiol, 2018, 41(1): 96-103.
[7] 李文静, 张志国, 田丰. 慢性心力衰竭患者血清FT3、miR-182、miR-126表达及与心衰严重程度、近期预后的关联性 [J]. 实验与检验医学, 2022, 40(3): 315-319.
[8] 仲崇霞, 刘益海, 房其军, 等载脂蛋白A1预测老年缺血性心肌病心衰患者预后的价值 [J]. 中华全科医学, 2022, 20(4): 546-549, 601.
[9] 刘武生. 参麦注射液联合美托洛尔治疗缺血性心肌病伴心力衰竭的临床研究 [J]. 中国合理用药探索, 2019, 16(7): 29-31, 35.
[10] RAZVI S, JABBAR A, PINGITORE A, et al. Thyroid hormones and cardiovascular function and diseases [J]. J Am Coll Cardiol, 2018, 71(16): 1781-1796.
[11] NIE X, MA X, XU Y, et al. Increased serum adipocyte fatty acid-binding protein levels are associated with decreased sensitivity to thyroid hormones in the euthyroid population [J]. Thyroid, 2020, 30(12): 1718-1723.
[12] 陈洁茹, 温艺超. 血清FT3对急性心力衰竭患者临床结局的影响 [J]. 广东医学, 2018, 39(15): 2345-2347, 2351.
[13] LIN K Y, WANG S Y, JIANG H, et al. Negative association between free triiodothyronine level and contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention [J]. BMC Nephrol, 2019, 20(1): 201.
[14] 陈德秀, 李家富, 冯健. 激活TGR5通过抑制CaN/NAFT3减轻ET-1诱导的心肌细胞肥大 [J]. 第三军医大学学报, 2019, 41(10): 939-946.
[15] 乔雅馨. 血清脂蛋白相关磷脂酶A2及FT3对急性心肌梗死后心力衰竭的预测价值研究 [D].延安:延安大学, 2021.
[16] ZHANG J, CHEN Y, DUAN Z. Development of a FT3-related prognostic model for patients with hepatitis B virus-related acute-on-chronic liver failure [J]. Bioengineered, 2022, 13(5): 12548-12557.
[17] HE W, HUANG C, WANG L, et al. The correlation between triiodothyronine and the severity of liver fibrosis [J]. BMC Endocr Disord, 2022, 22(1): 313.